News
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting ...
The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...
The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other ...
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...
US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...
The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results